<DOC>
	<DOCNO>NCT00650936</DOCNO>
	<brief_summary>The purpose study prospectively evaluate incidence hemodynamic compromise obtain long-term survival data patient AMPLATZER Septal Occluder</brief_summary>
	<brief_title>Closure Atrial Septal Defects With AMPLATZER Septal Occluder - Post Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Septal Defects</mesh_term>
	<mesh_term>Heart Septal Defects , Atrial</mesh_term>
	<criteria>Patients must meet inclusion criterion . A patient meet inclusion criterion he/she : indicate implantation AMPLATZER Septal Occluder occlusion secundum atrial septal defect ( Note : This include indication closure fenestration follow fenestrated Fontan procedure ) , willing able complete followup requirement study , sign inform consent ( legal representative sign inform consent ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Atrial</keyword>
	<keyword>Septal</keyword>
	<keyword>Defect</keyword>
</DOC>